Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Aggarwal

Showing results (111-120 of 170) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
Journal of the National Cancer Institute|September 22, 2018
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and NeckJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 studyNatasha B Leighl, Matthew D Hellmann, Rina Hui, et al.
Clinical Lung Cancer|October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With OligoprogressionCole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 29, 2020
Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, David Shimunov, Jason G Newman, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular AnalysisJacob E Till, Taylor A Black, Caren Gentile, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Pageof 17

Showing results (111-120 of 170) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
Journal of the National Cancer Institute|September 22, 2018
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and NeckJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 studyNatasha B Leighl, Matthew D Hellmann, Rina Hui, et al.
Clinical Lung Cancer|October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With OligoprogressionCole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 29, 2020
Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, David Shimunov, Jason G Newman, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular AnalysisJacob E Till, Taylor A Black, Caren Gentile, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Pageof 17